Close
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

FDA panel urges looser restrictions on diabetes drug Avandia

X
Your article was successfully shared with the contacts you provided.

Despite lingering concerns about increased susceptibility to heart problems when taking Avandia, a Type 2 diabetes medication, the majority of a Federal Drug Administration advisory panel suggested that the drug have looser restrictions. It will now be up to FDA Commissioner Margaret Hamburg to make a decision.